We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.

×

Aker to Promote Antarctic MPA Proposal at Clinton Global Initiative

Oslo / New York, September 2025 – Aker BioMarine and Aker QRILL Company will take part in the Clinton Global Initiative in...

The Superpowers of Krill: “The genome suggests species is extremely adaptable”

An interview with Nils Hoem, Chief Scientist at Aker BioMarine Antarctic krill may be small, but genetically it is a giant....

Krill oil supplementation helps preserve muscle strength and mass during diet-induced weight loss

Oslo, July 17 2025: A new study, led by the University of Glasgow’s School of Medicine, Dentistry and Nursing, shows that...

Continued positive momentum in the second quarter with double-digit revenue growth

Highlights second quarter 2025: • Q2 revenue reached USD 55.3 million, a 12% increase year-over-year, with adjusted EBITDA...

New Platform Unlocks 20 Years of Antarctic Krill Research

A new digital platform with 20 years of research on Antarctic krill and the Southern Ocean has now been launched by Aker...

Industry Takes Unprecedented Step to Drive Antarctic Marine Protection

Industry leader announces ambitions to establish one of the world's largest Marine Protected Areas, bridging nations for...

Aker BioMarine Appoints Bob Nelson as General Manager to its Houston Manufacturing Facility

Through teamwork, performance, and visionary leadership, Nelson sets his sights on “Building for the Future”

Aker BioMarine signs agreement for Lysoveta clinical trial

Oslo, 30 April 2025 – Aker BioMarine has signed an agreement with leading clinical research organization KGK Science Inc.,...

Aker BioMarine Delivers Strong Start to 2025 with Revenue and Earnings Growth

Oslo, 30 April 2025 – Aker BioMarine today reported its financial results for the first quarter of 2025, delivering solid...